£853
−60%vs Feb 2024Active06830591Private limited companyLondon
ALMOND PHARMA LTD
B68/10001
Summary
ALMOND PHARMA LTD is an active private limited company (company number 06830591) incorporated on 26 February 2009, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 28 February 2025, showing net assets of £853, with 1 employee on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 60% on the prior period (£2,139).
Peer position · net assets
By net assets it sits in the upper half of 603 comparable companies in London (median £440, upper quartile £92k).
02
Key dates
- Incorporated
- 26 February 200917 yrs ago
- Next accounts due
- 28 November 2026in 37 days
- Confirmation statement due
- 12 March 2027in 141 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
03
Activity
- SIC 72110
- Research and experimental development on biotechnology
- SIC 96090
- Other service activities n.e.c.
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
04
Financials
Not reported
Not disclosed
1
No changevs Feb 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 28 February 2025 | £853 | — | — | £1,694 | — | — | 1 |
| 28 February 2024 | £2,139 | — | — | £2,921 | — | — | 1 |
Current ratio1.68Comfortable
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
05
Firmoscan score
68 / 100 · grade B
| 50 | Starting scoreEvery scored company starts here |
| +10 | Positive net assetsNet assets £853 at 2025-02-28 |
| −8 | Net assets falling-60.1% vs prior period |
| +8 | Comfortable liquidityCurrent ratio 1.68 |
| +8 | EstablishedIncorporated 2009-02-26 (18 years) |
| 68 | Score, grade B |
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice. How the score is computed.
06
Ownership and control
- Mrs Joan Wimbainashe Mwanaka
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Ms Joan Wimbainashe Mwanaka
- owns 75–100% of shares
- owns 75–100% of shares
- owns 75–100% of shares
- holds 75–100% of voting rights
- holds 75–100% of voting rights
- holds 75–100% of voting rights
- can appoint or remove directors
- can appoint or remove directors
- can appoint or remove directors
- has significant influence or control
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
07
Timeline
- Confirmation statement duein 141 days
- Next accounts duein 37 days
- Accounts period endNet assets £853 · micro accounts
- Accounts period endNet assets £2,139 · micro accounts
- Incorporated
08
Similar companies in London
- THERAGLASS LIMITEDLondon · inc. Feb 2009
- CHAMPIONS ONCOLOGY UK LIMITEDLondon · inc. Mar 2009
- ARCIS AGTECH LIMITEDLondon · inc. Jan 2009
- HAOMA MEDICA LIMITEDLondon · inc. Jan 2009
- UBC LATE STAGE (UK) LIMITEDLondon · inc. Dec 2008
- GLYCAN INDUSTRIES CORPORATION LTDLondon · inc. Oct 2008
All companies incorporated on 26 February 2009 · in Feb 2009.
09
Reminders for ALMOND PHARMA LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.